Home › Funds › SILVERARC CAPITAL MANAGEMENT, LLC › ALKS
SILVERARC CAPITAL MANAGEMENT, LLC position in ALKS
ALKERMES PLC · Health Care
SILVERARC CAPITAL MANAGEMENT, LLC reported holding 300,427 shares of ALKS (ALKERMES PLC) in its Q3 2026 13F filing — a position valued at US$12.2M, representing 1.55% of its reported portfolio and ranking #19 among its reported holdings. SILVERARC CAPITAL MANAGEMENT, LLC has disclosed ALKS holdings in 6 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How SILVERARC CAPITAL MANAGEMENT, LLC's ALKS position evolved
SILVERARC CAPITAL MANAGEMENT, LLC first disclosed a stake in ALKS in Q3 2023 at 41,455 shares (US$1.2M). The position peaked in Q1 2026 at 460,314 shares, worth US$16.3M. Across 6 filings, SILVERARC CAPITAL MANAGEMENT, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 300,427 shares valued at US$12.2M — an increase of 186,933 shares quarter over quarter.. Notable position changes include a 75% trim in Q2 2026 (shares fell 23% over the following quarter), a 165% increase in Q3 2026 (shares rose 16% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 41.45K | $1.16M | New |
| Q1 2025 | 124.87K | $4.12M | New |
| Q3 2025 | 180.51K | $5.42M | New |
| Q1 2026 | 460.31K | $16.28M | New |
| Q2 2026 | 113.49K | $5.95M | Reduce |
| Q3 2026 | 300.43K | $12.17M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALKS and 13F data
ALKS (ALKERMES PLC) is a Health Care company. 38 other funds we track also report a position in ALKS — the largest reported positions include BAKER BROS. ADVISORS LP (US$524.6M), Renaissance Technologies (US$263.1M), Deep Track Capital, LP (US$209.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALKS
- BAKER BROS. ADVISORS LP 10.01M sh · $524.59M · Q2 2026
- Renaissance Technologies 6.49M sh · $263.13M · Q3 2026
- Deep Track Capital, LP 4.00M sh · $209.58M · Q2 2026
- Commodore Capital LP 3.00M sh · $157.19M · Q2 2026
- BVF INC/IL 2.15M sh · $112.90M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 1.94M sh · $101.54M · Q2 2026
- RTW INVESTMENTS, LP 1.67M sh · $87.62M · Q2 2026
- Soleus Capital Management, L.P. 1.03M sh · $53.93M · Q2 2026
More on SILVERARC CAPITAL MANAGEMENT, LLC
FAQ
How long has SILVERARC CAPITAL MANAGEMENT, LLC held ALKS?
SILVERARC CAPITAL MANAGEMENT, LLC has disclosed ALKS holdings in 6 of the last 13 reported quarters, going back to Q3 2023.
What is SILVERARC CAPITAL MANAGEMENT, LLC's current position in ALKS?
As of Q3 2026, SILVERARC CAPITAL MANAGEMENT, LLC holds 300.43K shares of ALKS (ALKERMES PLC), valued at $12.17M, representing 1.55% of its reported portfolio and ranking #19.
Has SILVERARC CAPITAL MANAGEMENT, LLC been buying or selling ALKS?
In the latest 13F filing (Q3 2026), SILVERARC CAPITAL MANAGEMENT, LLC increased its position in ALKS. The position peaked in Q1 2026 at 460.31K shares.
Which other funds hold ALKS?
Other major institutional holders of ALKS include BAKER BROS. ADVISORS LP, Renaissance Technologies, Deep Track Capital, LP, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.